| 钱南南,王文忠.孟鲁司特和鼻用糖皮质激素治疗小儿腺样体肥大研究进展[J].安徽医药,2017,21(3):435-438. |
| 孟鲁司特和鼻用糖皮质激素治疗小儿腺样体肥大研究进展 |
| Progress of the study on the treatment of adenoid hypertrophy in children with montelukast and nose use glucocorticoids |
| 投稿时间：2016-06-23 |
| DOI： |
| 中文关键词: 增殖腺/药物作用 孟鲁司特 糖皮质激素类 儿童 |
| 英文关键词: Adenoids/drug effects Montelukast Glucocorticoids Child |
| 基金项目: |
|
| 摘要点击次数: 2136 |
| 全文下载次数: 981 |
| 中文摘要: |
| 腺样体肥大(Adenoidal Hypertrophy,AH)是指由于反复的上呼吸道感染或其他原因使腺样体慢性发炎,发生病理学增生且引起相应症状。多数儿童因其伴随疾病如慢性扁桃体炎、慢性鼻窦炎、分泌性中耳炎等就诊,为耳鼻咽喉科门诊小儿多发病。目前腺样体肥大的主要治疗方法是手术切除,但手术风险及麻醉风险为多数近亲属权衡因素。孟鲁司特及鼻用糖皮质激素已被证实可缩小腺样体大小,缓解其伴随症状,因此,对孟鲁司特、鼻用糖皮质激素保守治疗小儿腺样体肥大研究进展进行综述,以寻求手术之外安全、有效的治疗方法。 |
| 英文摘要: |
| Adenoid hypertrophy (Hypertrophy Adenoidal,AH) is the result of repeated upper respiratory tract infection or other causes of chronic inflammation,pathological hyperplasia and cause the corresponding symptoms.Most children with its attendant diseases such as treatment of chronic tonsillitis,chronic sinusitis,otitis media,ear,nose and throat out-patient pediatric disease,at present the main method for the treatment of adenoid hypertrophy is surgical resection,but risk of surgery and anesthesia risk for most parents tradeoffs.Montelukast and nasal glucocorticoid have been shown to reduce the size of adenoids and alleviate symptoms associated with the Montelukast and nasal glucocorticoid conservative treatment in children with adenoidal hypertrophy of progress are reviewed in this paper,seeking to avoid surgery outside the safe and effective treatment method. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
